CN114316015A - Insect-resistant protein hRI and coding gene and application thereof - Google Patents
Insect-resistant protein hRI and coding gene and application thereof Download PDFInfo
- Publication number
- CN114316015A CN114316015A CN202111469961.3A CN202111469961A CN114316015A CN 114316015 A CN114316015 A CN 114316015A CN 202111469961 A CN202111469961 A CN 202111469961A CN 114316015 A CN114316015 A CN 114316015A
- Authority
- CN
- China
- Prior art keywords
- insect
- hri
- leu
- resistant
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 59
- 241000238631 Hexapoda Species 0.000 title claims abstract description 56
- 230000009261 transgenic effect Effects 0.000 claims abstract description 35
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 241000196324 Embryophyta Species 0.000 claims description 42
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 35
- 239000012634 fragment Substances 0.000 claims description 13
- 239000013598 vector Substances 0.000 claims description 13
- 241000255967 Helicoverpa zea Species 0.000 claims description 8
- 239000013612 plasmid Substances 0.000 claims description 6
- 244000061176 Nicotiana tabacum Species 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 3
- 235000009429 Gossypium barbadense Nutrition 0.000 claims description 2
- 244000299507 Gossypium hirsutum Species 0.000 claims description 2
- 235000018322 upland cotton Nutrition 0.000 claims description 2
- 238000009877 rendering Methods 0.000 claims 1
- 241000607479 Yersinia pestis Species 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 9
- 230000012010 growth Effects 0.000 abstract description 8
- 230000005764 inhibitory process Effects 0.000 abstract description 5
- 238000011160 research Methods 0.000 abstract description 3
- 206010061217 Infestation Diseases 0.000 abstract 1
- 241000208125 Nicotiana Species 0.000 description 30
- 102000004169 proteins and genes Human genes 0.000 description 19
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 18
- 241001147381 Helicoverpa armigera Species 0.000 description 17
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 229940088598 enzyme Drugs 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 238000012258 culturing Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 4
- 108010083644 Ribonucleases Proteins 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- LAPSXOAUPNOINL-YUMQZZPRSA-N Leu-Gly-Asp Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O LAPSXOAUPNOINL-YUMQZZPRSA-N 0.000 description 3
- 241000208128 Nicotiana glauca Species 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 238000012271 agricultural production Methods 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000009630 liquid culture Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000009465 prokaryotic expression Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 2
- NKBQZKVMKJJDLX-SRVKXCTJSA-N Arg-Glu-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NKBQZKVMKJJDLX-SRVKXCTJSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- QKCZZAZNMMVICF-DCAQKATOSA-N Gln-Leu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O QKCZZAZNMMVICF-DCAQKATOSA-N 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 2
- 239000003392 amylase inhibitor Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 108010004073 cysteinylcysteine Proteins 0.000 description 2
- 108010016616 cysteinylglycine Proteins 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- SCPRYBYMKVYVND-UHFFFAOYSA-N 2-[[2-[[1-(2-amino-4-methylpentanoyl)pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)CC(N)C(=O)N1CCCC1C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(O)=O SCPRYBYMKVYVND-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UWQJHXKARZWDIJ-ZLUOBGJFSA-N Ala-Ala-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(O)=O UWQJHXKARZWDIJ-ZLUOBGJFSA-N 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- WRDANSJTFOHBPI-FXQIFTODSA-N Ala-Arg-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N WRDANSJTFOHBPI-FXQIFTODSA-N 0.000 description 1
- DWINFPQUSSHSFS-UVBJJODRSA-N Ala-Arg-Trp Chemical compound N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O DWINFPQUSSHSFS-UVBJJODRSA-N 0.000 description 1
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 1
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 1
- LJFNNUBZSZCZFN-WHFBIAKZSA-N Ala-Gly-Cys Chemical compound N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)O LJFNNUBZSZCZFN-WHFBIAKZSA-N 0.000 description 1
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 1
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 1
- AUFACLFHBAGZEN-ZLUOBGJFSA-N Ala-Ser-Cys Chemical compound N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O AUFACLFHBAGZEN-ZLUOBGJFSA-N 0.000 description 1
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 1
- 229940122816 Amylase inhibitor Drugs 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- ZEAYJGRKRUBDOB-GARJFASQSA-N Arg-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ZEAYJGRKRUBDOB-GARJFASQSA-N 0.000 description 1
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 1
- YKZJPIPFKGYHKY-DCAQKATOSA-N Arg-Leu-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O YKZJPIPFKGYHKY-DCAQKATOSA-N 0.000 description 1
- HUZGPXBILPMCHM-IHRRRGAJSA-N Asn-Arg-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HUZGPXBILPMCHM-IHRRRGAJSA-N 0.000 description 1
- YNSCBOUZTAGIGO-ZLUOBGJFSA-N Asn-Asn-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N)C(=O)N YNSCBOUZTAGIGO-ZLUOBGJFSA-N 0.000 description 1
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 1
- WQSCVMQDZYTFQU-FXQIFTODSA-N Asn-Cys-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WQSCVMQDZYTFQU-FXQIFTODSA-N 0.000 description 1
- ULRPXVNMIIYDDJ-ACZMJKKPSA-N Asn-Glu-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N ULRPXVNMIIYDDJ-ACZMJKKPSA-N 0.000 description 1
- ORJQQZIXTOYGGH-SRVKXCTJSA-N Asn-Lys-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ORJQQZIXTOYGGH-SRVKXCTJSA-N 0.000 description 1
- PLTGTJAZQRGMPP-FXQIFTODSA-N Asn-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O PLTGTJAZQRGMPP-FXQIFTODSA-N 0.000 description 1
- IXIWEFWRKIUMQX-DCAQKATOSA-N Asp-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O IXIWEFWRKIUMQX-DCAQKATOSA-N 0.000 description 1
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 1
- QQXOYLWJQUPXJU-WHFBIAKZSA-N Asp-Cys-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CS)C(=O)NCC(O)=O QQXOYLWJQUPXJU-WHFBIAKZSA-N 0.000 description 1
- VFUXXFVCYZPOQG-WDSKDSINSA-N Asp-Glu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VFUXXFVCYZPOQG-WDSKDSINSA-N 0.000 description 1
- QNFRBNZGVVKBNJ-PEFMBERDSA-N Asp-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QNFRBNZGVVKBNJ-PEFMBERDSA-N 0.000 description 1
- RTXQQDVBACBSCW-CFMVVWHZSA-N Asp-Ile-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RTXQQDVBACBSCW-CFMVVWHZSA-N 0.000 description 1
- AITKTFCQOBRJTG-CIUDSAMLSA-N Asp-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)O)N AITKTFCQOBRJTG-CIUDSAMLSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- HRVQDZOWMLFAOD-BIIVOSGPSA-N Asp-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N)C(=O)O HRVQDZOWMLFAOD-BIIVOSGPSA-N 0.000 description 1
- XWKPSMRPIKKDDU-RCOVLWMOSA-N Asp-Val-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O XWKPSMRPIKKDDU-RCOVLWMOSA-N 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 101001106957 Bos taurus Ribonuclease pancreatic Proteins 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- KEBJBKIASQVRJS-WDSKDSINSA-N Cys-Gln-Gly Chemical compound C(CC(=O)N)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CS)N KEBJBKIASQVRJS-WDSKDSINSA-N 0.000 description 1
- YZKOXEJTLWZOQL-GUBZILKMSA-N Cys-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CS)N YZKOXEJTLWZOQL-GUBZILKMSA-N 0.000 description 1
- BDWIZLQVVWQMTB-XKBZYTNZSA-N Cys-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)N)O BDWIZLQVVWQMTB-XKBZYTNZSA-N 0.000 description 1
- GUKYYUFHWYRMEU-WHFBIAKZSA-N Cys-Gly-Asp Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O GUKYYUFHWYRMEU-WHFBIAKZSA-N 0.000 description 1
- UPURLDIGQGTUPJ-ZKWXMUAHSA-N Cys-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N UPURLDIGQGTUPJ-ZKWXMUAHSA-N 0.000 description 1
- UXIYYUMGFNSGBK-XPUUQOCRSA-N Cys-Gly-Val Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O UXIYYUMGFNSGBK-XPUUQOCRSA-N 0.000 description 1
- UEHCDNYDBBCQEL-CIUDSAMLSA-N Cys-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N UEHCDNYDBBCQEL-CIUDSAMLSA-N 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- MINZLORERLNSPP-ACZMJKKPSA-N Gln-Asn-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N MINZLORERLNSPP-ACZMJKKPSA-N 0.000 description 1
- PCKOTDPDHIBGRW-CIUDSAMLSA-N Gln-Cys-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N)N)CN=C(N)N PCKOTDPDHIBGRW-CIUDSAMLSA-N 0.000 description 1
- RRBLZNIIMHSHQF-FXQIFTODSA-N Gln-Gln-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N RRBLZNIIMHSHQF-FXQIFTODSA-N 0.000 description 1
- PNENQZWRFMUZOM-DCAQKATOSA-N Gln-Glu-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O PNENQZWRFMUZOM-DCAQKATOSA-N 0.000 description 1
- IOFDDSNZJDIGPB-GVXVVHGQSA-N Gln-Leu-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IOFDDSNZJDIGPB-GVXVVHGQSA-N 0.000 description 1
- VLOLPWWCNKWRNB-LOKLDPHHSA-N Gln-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O VLOLPWWCNKWRNB-LOKLDPHHSA-N 0.000 description 1
- ITYRYNUZHPNCIK-GUBZILKMSA-N Glu-Ala-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O ITYRYNUZHPNCIK-GUBZILKMSA-N 0.000 description 1
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 1
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- ATVYZJGOZLVXDK-IUCAKERBSA-N Glu-Leu-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O ATVYZJGOZLVXDK-IUCAKERBSA-N 0.000 description 1
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
- JHSRJMUJOGLIHK-GUBZILKMSA-N Glu-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N JHSRJMUJOGLIHK-GUBZILKMSA-N 0.000 description 1
- DMYACXMQUABZIQ-NRPADANISA-N Glu-Ser-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O DMYACXMQUABZIQ-NRPADANISA-N 0.000 description 1
- IXKRSKPKSLXIHN-YUMQZZPRSA-N Gly-Cys-Leu Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(O)=O IXKRSKPKSLXIHN-YUMQZZPRSA-N 0.000 description 1
- COVXELOAORHTND-LSJOCFKGSA-N Gly-Ile-Val Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O COVXELOAORHTND-LSJOCFKGSA-N 0.000 description 1
- TWTPDFFBLQEBOE-IUCAKERBSA-N Gly-Leu-Gln Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O TWTPDFFBLQEBOE-IUCAKERBSA-N 0.000 description 1
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 1
- LLZXNUUIBOALNY-QWRGUYRKSA-N Gly-Leu-Lys Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN LLZXNUUIBOALNY-QWRGUYRKSA-N 0.000 description 1
- GJHWILMUOANXTG-WPRPVWTQSA-N Gly-Val-Arg Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GJHWILMUOANXTG-WPRPVWTQSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- MWXBCJKQRQFVOO-DCAQKATOSA-N His-Cys-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CN=CN1)N MWXBCJKQRQFVOO-DCAQKATOSA-N 0.000 description 1
- LVXFNTIIGOQBMD-SRVKXCTJSA-N His-Leu-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O LVXFNTIIGOQBMD-SRVKXCTJSA-N 0.000 description 1
- YEKYGQZUBCRNGH-DCAQKATOSA-N His-Pro-Ser Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)N)C(=O)N[C@@H](CO)C(=O)O YEKYGQZUBCRNGH-DCAQKATOSA-N 0.000 description 1
- PZAJPILZRFPYJJ-SRVKXCTJSA-N His-Ser-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O PZAJPILZRFPYJJ-SRVKXCTJSA-N 0.000 description 1
- OONBGFHNQVSUBF-KBIXCLLPSA-N Ile-Gln-Cys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(O)=O OONBGFHNQVSUBF-KBIXCLLPSA-N 0.000 description 1
- LKACSKJPTFSBHR-MNXVOIDGSA-N Ile-Gln-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N LKACSKJPTFSBHR-MNXVOIDGSA-N 0.000 description 1
- RWHRUZORDWZESH-ZQINRCPSSA-N Ile-Trp-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RWHRUZORDWZESH-ZQINRCPSSA-N 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- CZCSUZMIRKFFFA-CIUDSAMLSA-N Leu-Ala-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O CZCSUZMIRKFFFA-CIUDSAMLSA-N 0.000 description 1
- MJOZZTKJZQFKDK-GUBZILKMSA-N Leu-Ala-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(N)=O MJOZZTKJZQFKDK-GUBZILKMSA-N 0.000 description 1
- CQQGCWPXDHTTNF-GUBZILKMSA-N Leu-Ala-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O CQQGCWPXDHTTNF-GUBZILKMSA-N 0.000 description 1
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 1
- DUBAVOVZNZKEQQ-AVGNSLFASA-N Leu-Arg-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CCCN=C(N)N DUBAVOVZNZKEQQ-AVGNSLFASA-N 0.000 description 1
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 1
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 1
- NFHJQETXTSDZSI-DCAQKATOSA-N Leu-Cys-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NFHJQETXTSDZSI-DCAQKATOSA-N 0.000 description 1
- HUEBCHPSXSQUGN-GARJFASQSA-N Leu-Cys-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N HUEBCHPSXSQUGN-GARJFASQSA-N 0.000 description 1
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 1
- DPWGZWUMUUJQDT-IUCAKERBSA-N Leu-Gln-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O DPWGZWUMUUJQDT-IUCAKERBSA-N 0.000 description 1
- RSFGIMMPWAXNML-MNXVOIDGSA-N Leu-Gln-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RSFGIMMPWAXNML-MNXVOIDGSA-N 0.000 description 1
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
- KVMULWOHPPMHHE-DCAQKATOSA-N Leu-Glu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KVMULWOHPPMHHE-DCAQKATOSA-N 0.000 description 1
- FIYMBBHGYNQFOP-IUCAKERBSA-N Leu-Gly-Gln Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N FIYMBBHGYNQFOP-IUCAKERBSA-N 0.000 description 1
- VGPCJSXPPOQPBK-YUMQZZPRSA-N Leu-Gly-Ser Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O VGPCJSXPPOQPBK-YUMQZZPRSA-N 0.000 description 1
- IFMPDNRWZZEZSL-SRVKXCTJSA-N Leu-Leu-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(O)=O IFMPDNRWZZEZSL-SRVKXCTJSA-N 0.000 description 1
- IRMLZWSRWSGTOP-CIUDSAMLSA-N Leu-Ser-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O IRMLZWSRWSGTOP-CIUDSAMLSA-N 0.000 description 1
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 1
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 1
- WGCKDDHUFPQSMZ-ZPFDUUQYSA-N Lys-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCCN WGCKDDHUFPQSMZ-ZPFDUUQYSA-N 0.000 description 1
- LMVOVCYVZBBWQB-SRVKXCTJSA-N Lys-Asp-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LMVOVCYVZBBWQB-SRVKXCTJSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 1
- CTJUSALVKAWFFU-CIUDSAMLSA-N Lys-Ser-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N CTJUSALVKAWFFU-CIUDSAMLSA-N 0.000 description 1
- ONGCSGVHCSAATF-CIUDSAMLSA-N Met-Ala-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O ONGCSGVHCSAATF-CIUDSAMLSA-N 0.000 description 1
- HLZORBMOISUNIV-DCAQKATOSA-N Met-Ser-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C HLZORBMOISUNIV-DCAQKATOSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 1
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 1
- QNZLIVROMORQFH-BQBZGAKWSA-N Pro-Gly-Cys Chemical compound C1C[C@H](NC1)C(=O)NCC(=O)N[C@@H](CS)C(=O)O QNZLIVROMORQFH-BQBZGAKWSA-N 0.000 description 1
- FMLRRBDLBJLJIK-DCAQKATOSA-N Pro-Leu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FMLRRBDLBJLJIK-DCAQKATOSA-N 0.000 description 1
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 1
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- OOKCGAYXSNJBGQ-ZLUOBGJFSA-N Ser-Asn-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OOKCGAYXSNJBGQ-ZLUOBGJFSA-N 0.000 description 1
- ZXLUWXWISXIFIX-ACZMJKKPSA-N Ser-Asn-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZXLUWXWISXIFIX-ACZMJKKPSA-N 0.000 description 1
- KMWFXJCGRXBQAC-CIUDSAMLSA-N Ser-Cys-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CO)N KMWFXJCGRXBQAC-CIUDSAMLSA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- NLOAIFSWUUFQFR-CIUDSAMLSA-N Ser-Leu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O NLOAIFSWUUFQFR-CIUDSAMLSA-N 0.000 description 1
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 1
- GVIGVIOEYBOTCB-XIRDDKMYSA-N Ser-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC(C)C)C(O)=O)=CNC2=C1 GVIGVIOEYBOTCB-XIRDDKMYSA-N 0.000 description 1
- GZSZPKSBVAOGIE-CIUDSAMLSA-N Ser-Lys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O GZSZPKSBVAOGIE-CIUDSAMLSA-N 0.000 description 1
- FBLNYDYPCLFTSP-IXOXFDKPSA-N Ser-Phe-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FBLNYDYPCLFTSP-IXOXFDKPSA-N 0.000 description 1
- HHJFMHQYEAAOBM-ZLUOBGJFSA-N Ser-Ser-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O HHJFMHQYEAAOBM-ZLUOBGJFSA-N 0.000 description 1
- VFWQQZMRKFOGLE-ZLUOBGJFSA-N Ser-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O VFWQQZMRKFOGLE-ZLUOBGJFSA-N 0.000 description 1
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 1
- PYTKULIABVRXSC-BWBBJGPYSA-N Ser-Ser-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PYTKULIABVRXSC-BWBBJGPYSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ZUXQFMVPAYGPFJ-JXUBOQSCSA-N Thr-Ala-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN ZUXQFMVPAYGPFJ-JXUBOQSCSA-N 0.000 description 1
- ISLDRLHVPXABBC-IEGACIPQSA-N Thr-Leu-Trp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ISLDRLHVPXABBC-IEGACIPQSA-N 0.000 description 1
- IVDFVBVIVLJJHR-LKXGYXEUSA-N Thr-Ser-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IVDFVBVIVLJJHR-LKXGYXEUSA-N 0.000 description 1
- UIRPULWLRODAEQ-QEJZJMRPSA-N Trp-Ser-Glu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 UIRPULWLRODAEQ-QEJZJMRPSA-N 0.000 description 1
- ZAGPDPNPWYPEIR-SRVKXCTJSA-N Tyr-Cys-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O ZAGPDPNPWYPEIR-SRVKXCTJSA-N 0.000 description 1
- XXROXFHCMVXETG-UWVGGRQHSA-N Val-Gly-Val Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXROXFHCMVXETG-UWVGGRQHSA-N 0.000 description 1
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
- OTJMMKPMLUNTQT-AVGNSLFASA-N Val-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N OTJMMKPMLUNTQT-AVGNSLFASA-N 0.000 description 1
- BMOFUVHDBROBSE-DCAQKATOSA-N Val-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N BMOFUVHDBROBSE-DCAQKATOSA-N 0.000 description 1
- WDIWOIRFNMLNKO-ULQDDVLXSA-N Val-Leu-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WDIWOIRFNMLNKO-ULQDDVLXSA-N 0.000 description 1
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 1
- 235000010726 Vigna sinensis Nutrition 0.000 description 1
- 244000042314 Vigna unguiculata Species 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012881 co-culture medium Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010064235 lysylglycine Proteins 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 108010073101 phenylalanylleucine Proteins 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Abstract
The invention provides an insect-resistant protein hRI, and a coding gene and application thereof, wherein the amino acid sequence of the insect-resistant protein hRI is shown as a sequence 1 in a sequence table. The gene sequence is shown as a sequence 2 in a sequence table. The application of the insect-resistant protein hRI and the gene in improving the insect resistance of plants. hRI is applied to the insect-resistant research of plants for the first time, and the insect-resistant effect is good, and the inhibition rate (calculated according to the weight of the pests) of the transgenic insect-resistant plants on the growth of the pests is more than 60 percent; transgenic insect-resistant plants were subjected to very mild insect infestation compared to controls.
Description
Technical Field
The invention relates to the technical field of genetic engineering, in particular to an insect-resistant protein hRI, and a coding gene and application thereof.
Background
Insect pests cause the loss of the yield and quality of crops, and seriously affect the stability and sustainable development of agricultural production. The chemical insecticide is adopted to control insect pests, so that the serious problems of pesticide residue, pest resistance evolution, natural enemy killing, environmental pollution and the like are brought while crops are protected. The transgenic insect-resistant crops developed by utilizing the transgenic technology have the characteristics of high efficiency, low cost, environmental protection and the like.
At present, the insect-resistant genes expressed on transgenic insect-resistant plants in agricultural production mainly comprise delta-endotoxin (Bt toxic protein) from bacillus thuringiensis, protease/amylase inhibitor (such as cowpea protease inhibitor CpTI and alpha-amylase inhibitor), plant-mediated RNAi and the like.
In the field of plant pest-resistant gene engineering, the types of pest-resistant genes available in the current production are very limited. The long-term use of the insect-resistant genes inevitably causes the resistance evolution of pests, so that the insect resistance of transgenic plants is reduced or lost, and the insect damage threat is confronted again by using agricultural production. With the popularization of the transgenic insect-resistant plants and the extension of the planting years, the problem of resistance evolution of pests is more and more prominent, and a new insect-resistant gene or means is urgently required to be searched.
Disclosure of Invention
The invention aims to provide an insect-resistant protein hRI, and a coding gene and application thereof, so as to solve the problems of single excellent insect-resistant gene and insect resistance evolution of the existing transgenic plant, and thus provide a new insect-resistant gene resource for plant insect-resistant genetic engineering.
The purpose of the invention is realized by the following technical scheme: an insect-resistant protein hRI, wherein the amino acid sequence of the insect-resistant protein hRI is shown as a sequence 1 in a sequence table.
The gene of the insect-resistant protein hRI is coded and has a sequence shown as a sequence 2 in a sequence table.
A recombinant vector containing the gene fragment. The recombinant vector is constructed by the following method: the gene fragment shown in the sequence 2 in the sequence table is connected to the pBIN438 plasmid, thereby constituting the plant expression vector pBIN 438-hRI.
The recombinant strain containing the recombinant vector is agrobacterium tumefaciens.
The application of the insect-resistant protein hRI and the gene in improving the insect resistance of plants.
The gene fragment is introduced into a target plant to obtain a transgenic plant, and the insect-resistant protein hRI is expressed in the transgenic plant, so that the insect resistance of the transgenic plant is higher than that of the target plant.
The above gene fragment is introduced into a target plant by the above recombinant vector.
The insect resistance refers to cotton bollworm resistance.
The target plant is upland cotton or tobacco.
The insect-resistant protein hRI used in the invention is a Human ribonucleic acid inhibitor (hRI) which is related to the degradation inhibition of RNA. hRI binds to RNase1, bovine RNase A and other ribonucleases very strongly (dissociation constant 3.5X 10)-14M-4.5×10-14M). hRI is applied to the insect-resistant research of plants for the first time, and the insect-resistant effect is good, and the inhibition rate (calculated according to the weight of the pests) of the transgenic insect-resistant plants on the growth of the pests is more than 60 percent; transgenic insect-resistant plants are very slightly damaged by pests compared to controls.
Degrading enzyme inhibitor genes reported to be used for plant insect-resistant research are all directed to starch and protein; the technology of the invention is based on long-term laboratory verification and analysis, has solid experimental evidence and better application value, can be used as a reserve resource of the existing insect-resistant gene, and is used for plant insect-resistant gene engineering.
Drawings
FIG. 1 shows the inhibitory activity of recombinant hRI on the activity of midgut RNase in Heliothis armigera. (a) hRI protective effect on dsRNA1 (b) protective effect of hRI on dsRNA 2; m: DNA Marker; 1: dsRNA untreated group; 2: dsRNA + hRI untreated group; 3-6: different amounts of hRI experimental groups; 7: RRI (commercial recombinant RNA inhibitor, Takara, 2313Q) control group; 8: EGFP control group.
FIG. 2 is a schematic diagram of the vector construction of pBIN 438-hRI.
FIG. 3 PCR identification of genomic DNA of transgenic hRI tobacco plants. The number designation is transgenic plant, WT is wild type plant.
FIG. 4 RT-PCR identification of hRI transgenic tobacco plants. The number designation is transgenic plant, WT is wild type plant.
FIG. 524 h shows biting of the tobacco lamina. hRI-2, hRI-11, hRI-12 are three tobacco plants expressing hRI, WT is a non-transgenic wild type control.
FIG. 6 shows weight changes of Helicoverpa armigera with tobacco leaf taken as feed hRI.
Detailed Description
The technical solution of the present invention will be described in detail with reference to specific examples. The test conditions and operations not mentioned in the examples of the present invention are performed according to the conventional methods in the art, and those skilled in the art can refer to the related art books, such as: guillain, SammBruk et al, molecular cloning, Experimental Manual, 4 th edition (2017), et al.
Example 1
Activity analysis of RNase inhibitor hRI protein
Adopting RT-PCR technology to amplify human lung tissue cDNA to obtain hRI coding gene sequence, wherein the primer sequence is:
Hrif:5'-CACTCTTCACCTCCACCA-3'
hrir:5'-CTGAGCGTTTCTCTTCAAACC-3'
PCR reactivity program: pre-denaturation (95 ℃, 3min), 35 amplifications (95 ℃ 10 s; 52 ℃ annealing 30s, 72 ℃ extension 90s), and re-extension (72 ℃, 10 min). Gel electrophoresis, after the gel recovery of the target band, cloning to pUCm-T vector by enzyme linkage, and verifying through transformation, screening and sequencing test.
Preparing a prokaryotic expression vector pET17b-TC capable of carrying out TC directional cloning by using a TC cloning method (refer to Chinese invention patent: TC vector for gene directional cloning and preparation and use methods thereof, patent number CN 201210436709.7); the plasmid vector fragment is recovered by XcmI digestion. Using primers:
HRPepf:5'-ATGAGCCTGGACATCCAGAGCCTGGACATCCAGTGTG-3'
HRPepr:5'-TCAGGAGATGACCCTCAGGGATGGCTTGTCCTTCTCCA-3'
the hRI gene sequence on pUCm-T was amplified, recovered by gel electrophoresis, and ligated to pET-17b-TC large fragment. The hRI gene prokaryotic expression plasmid is obtained after transformation, screening and identification, and then BL21(DE3) pLysS escherichia coli competence is introduced.
hRI protein isolation and purification were performed using His-Tag technology: inducing hRI protein expression by IPTG, and detecting hRI protein expression product by SDS-PAGE; resuspending the induced bacteria with 10mL of Tris-HCl lysate (containing lysozyme), standing at 4 ℃ for 30min to lyse the bacteria, and then carrying out ultrasonication; the cleaved samples were subjected to imidazole washing and Ni column elution according to the High Affinity Ni-NTA Resin instructions, and the resulting purified recombinant hRI protein was finally examined by SDS-PAGE.
Inhibition assay of recombinant hRI protein on intestinal juice ribonuclease activity in Helicoverpa armigera: by taking a commercial RNA inhibitor as a control, green fluorescent protein (EGFP) or His-hRI with different amounts is respectively mixed with 0.5 mu L of midgut digestive juice of cotton bollworm and buffer solution, protein eluent is supplemented to 7 mu L, after 30min of metal bath at 37 ℃, 60ng of dsRNA is respectively added and rapidly mixed, 1h of metal bath at 37 ℃ and 5min of water bath at 85 ℃. RNA electrophoresis was performed on a 1% agarose gel prepared with DEPC water to examine the degradation of dsRNA. The results are shown in FIG. 1.
As shown in FIG. 1, under the same experimental conditions, the results of the negative control group (lane 1) showed that the buffer used in the experiment had no degradation effect on dsRNA; the dsRNA of the experimental group (lane 8) without hRI is degraded more completely, which reflects that the midgut enzyme of cotton bollworm has stronger destructive effect on feeding dsRNA under natural condition; partial degradation of the dsRNA occurred with the addition of the commercial inhibitor RRI (lane 7); in the experimental groups ( lanes 3, 4, 5 and 6) with different hRI dosages, the degradation degree of dsRNA is decreased with the increase of the dosage (0, 0.25, 0.5 and 1 muL) of hRI, and the activity of intestinal enzyme in cotton bollworm is obviously inhibited by the recombinant hRI protein, which shows that hRI has obvious degradation inhibition effect on dsRNA. The results show that the prokaryotic expression of hRI has obvious effect in inhibiting degradation of dsRNA by mesenteric enzymes.
Example 2
Obtaining of transgenic tobacco with ribonuclease gene
Construction of plant expression vectors: designing specific primers of hripBf and hripSr, wherein the hripBf introduces a Kozak sequence and a BamH I enzyme cutting site, and the hripSr introduces a Sal I enzyme cutting site:
hripBf:5'-CGCGGATCCAACAATGGCTAGCCTGGACATCCAGA-3'
hripSr:5'-GCAGGTCGACCCTCAGGAGATGAC-3'
hRI gene was PCR amplified using the primers and recovered by gel electrophoresis. The pBIN438-X plasmid and the recovered fragment were each double-digested with restriction enzymes BamH I and Sal I. The digestion system (50. mu.L) was: restriction enzymes are respectively 0.8 mu L and 4 mu L of corresponding endonuclease Buffer, 34.3 mu L of plasmid is cut by enzyme, the plasmid is cut by enzyme overnight at 37 ℃, a carrier framework and a target segment are recovered by electrophoresis, and the concentration of the recovered product is estimated. Enzyme-linked, transformed, screened and identified according to the molar ratio of the vector fragment to the target fragment of 1:3-1: 10. The PCR identification primer is hripBf/Sr, and the restriction enzymes used for enzyme digestion identification are EcoR I and Hind III. The structure of the constructed plant expression vector pBIN438X-hRI is shown in figure 2.
Obtaining sterile seedlings and genetically transforming: selecting plump wild tobacco seeds to remove impurities, sequentially sterilizing with alcohol and NaClO solution, and uniformly planting in MS solid culture medium (Murashige and Skoog solid culture medium); placing the plant in a plant growth box for culturing under the following conditions: the temperature is 28 +/-1 ℃, the relative humidity is 65 +/-5%, and the photoperiod is 16L: 8D. Under aseptic conditions, tobacco seedlings of appropriate size were transferred to tissue culture flasks containing MS solid medium. And when the height of the aseptic seedling reaches about 10cm, taking the leaf to perform agrobacterium-mediated leaf disc transformation. The method comprises the following steps: (1) pre-culturing leaves: shearing well-grown sterile wild tobacco leaves into squares (about 1cm multiplied by 1cm in size), uniformly paving the leaves on an MS solid culture medium containing no antibiotics with forceps in a manner that the back faces the culture medium, and culturing for 2d in an artificial climate box; (2) and (3) agrobacterium tumefaciens expanding culture: agrobacterium containing recombinant plasmid pBIN438X-hRI is taken from an ultralow temperature refrigerator at minus 80 ℃, activated at 220rpm/min at 28 ℃ for 24 hours and then transferred into 150mL LB liquid medium for amplification culture until logarithmic phase; (3) concentrating bacterial liquid: centrifuging the thalli in the growth period of the mobile phone at 4 ℃, washing the thalli for 2 times by using an MS liquid culture medium, and then suspending the thalli in 100mL of MS liquid culture medium; (4) infection: gently clamping the pre-cultured leaf into MS liquid heavy suspension, shaking for infection for 15min, placing the leaf on sterilized filter paper, sucking off excessive liquid, clamping the leaf with the back facing downwards, placing into a plate containing co-culture medium, and wrapping the plate with newspaper for dark culture for 2 d; (5) cleaning leaves and selectively culturing; sterile ddH is used first2O washing the leaves for 3 times, finally washing the leaves for 1 time by using an MS liquid culture medium,placing the leaf with the back face facing downwards on a selective differentiation culture medium for selective culture; (6) and (4) continuing culturing: cutting off the differentiated bud, inserting the bud into a tissue culture bottle for rooting culture, finally, when the transgenic tobacco grows to about 10cm, lightly taking out the regenerated plant from the tissue culture bottle by using long tweezers, washing the root by using flowing cold water, removing the residual tissue culture medium, and then transferring the regenerated plant into soil.
Molecular identification of transgenic tobacco: extracting DNA of tobacco leaves by a CTAB method, amplifying the DNA by using a specific identification primer, and detecting hRI whether the DNA is integrated into a tobacco genome, wherein the primer sequence is as follows:
RNH1igF:5'-CAGCAGTGCCAAGTGGTCAG-3'
RNH1igR:5-'CAATGCCGCACAGGTCCC-3'
identification of transcription levels: extracting total RNA of fresh tobacco leaves by using TRIzol reagent, carrying out reverse transcription, and using wild type tobacco total RNA as a control. The primers are used for RT-PCR amplification to identify whether the target gene is transcribed. The identification process needs to be independently extracted at least twice, and PCR or RT-PCR identification is carried out twice each time to ensure the accuracy of the result. Transgenic plants were characterized at the genomic level (FIG. 3) and at the transcriptional level (FIG. 4).
Example 3
Insect resistance analysis of transgenic tobacco
Cutting the artificial feed into small pieces of 0.5cm × 0.5cm, placing in a sterile culture dish, inoculating the bollworm egg larva to the feed, and culturing to 2-year-old (body length of 0.42cm-0.62cm) for insect test analysis. Selecting 3 plants from T1 generation single copy transgenic plant line, selecting 3 tobacco leaves with consistent growth vigor for feeding bollworm larvae, and selecting leaves with consistent growth vigor from wild tobacco planted at the same period for feeding the bollworm as a control. 3 single copies of tobacco of the same gene were set as an inter-group repeat to reduce errors due to different gene insertion sites; 3 leaves of the same tobacco plant are set to be subjected to repeated tests in a group, so that human errors caused by leaf selection are reduced; each group of bollworm was weighed 3 times to reduce the occasional error in weight measurement, and the average was taken during subsequent data processing. 16 cotton bollworm larvae with the same growth vigor and weight are selected from the cotton bollworms of 2 instars and put into a locker box with blades. Weighing the weight of the cotton bollworms every 24 hours, counting the residual quantity of the cotton bollworms, and counting the data to 120 hours. And observing the biting condition of the leaves at 24h and taking pictures for recording. During the period of worm test, the lockbox is cleaned and the fresh tobacco leaf is replaced every 24 h. And finally, calculating the mean weight of the cotton bollworms according to the statistical data, and comparing the difference between the mean weights of the cotton bollworms in different groups through single-factor variance analysis by using IBM SPSS Statistics 20 software. And drawing a mean body weight line graph of the cotton bollworms according to the statistical analysis result by using Excel 2016 software.
The biting condition of the tobacco leaves for 24h was recorded by photographing, and the result is shown in the figure (fig. 5). The results show that the transgenic hRI experimental group and the control group (wild type WT) all have different degrees of bite damage after being fed with the second-instar cotton bollworm larvae for 24h, wherein the bite condition of wild type tobacco leaves is more serious, and the bite condition of the transgenic hRI tobacco leaves is less. The insect resistance of the hRI transgenic tobacco is obviously improved.
The mean weight gain of the bollworms in five time periods of 24h, 48h, 72h, 96h and 120h in the wild-type tobacco and the transformed hRI tobacco was counted (Table 1) and a line graph of the mean weight gain of the bollworms was plotted (FIG. 6).
Table 1: mean body weight (g) of bollworm in different time periods with feeding rotor hRI
Note: different lowercase letters in the same column indicate that there is a significant difference in the level P < 0.05; different capital letters in the same column indicate that the difference is extremely significant in the P < 0.01 level difference.
The weight growth trend shows that: in the same time period, the feeding time of the tobacco group of the transgenic hRI tobacco is obviously lower than that of the wild type tobacco, the feeding time of the tobacco group of the transgenic hRI tobacco is obviously different from that of the wild type tobacco at 48h, the difference reaches an extremely obvious level at the beginning of 72h, and the result shows that the growth of the cotton bollworm larvae of the transgenic hRI tobacco has obvious inhibiting effect. There was no significant difference between the mean body weights of the 3 groups of Helicoverpa armigera fed transgenic hRI tobacco, indicating that the insect-inhibitory ability of transgenic hRI tobacco was not affected by the gene insertion site in the insect test analysis.
Sequence listing
<110> university of Hebei
<120> insect-resistant protein hRI, and coding gene and application thereof
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 461
<212> PRT
<213> Human (Human)
<400> 1
Met Ser Leu Asp Ile Gln Ser Leu Asp Ile Gln Cys Glu Glu Leu Ser
1 5 10 15
Asp Ala Arg Trp Ala Glu Leu Leu Pro Leu Leu Gln Gln Cys Gln Val
20 25 30
Val Arg Leu Asp Asp Cys Gly Leu Thr Glu Ala Arg Cys Lys Asp Ile
35 40 45
Ser Ser Ala Leu Arg Val Asn Pro Ala Leu Ala Glu Leu Asn Leu Arg
50 55 60
Ser Asn Glu Leu Gly Asp Val Gly Val His Cys Val Leu Gln Gly Leu
65 70 75 80
Gln Thr Pro Ser Cys Lys Ile Gln Lys Leu Ser Leu Gln Asn Cys Cys
85 90 95
Leu Thr Gly Ala Gly Cys Gly Val Leu Ser Ser Thr Leu Arg Thr Leu
100 105 110
Pro Thr Leu Gln Glu Leu His Leu Ser Asp Asn Leu Leu Gly Asp Ala
115 120 125
Gly Leu Gln Leu Leu Cys Glu Gly Leu Leu Asp Pro Gln Cys Arg Leu
130 135 140
Glu Lys Leu Gln Leu Glu Tyr Cys Ser Leu Ser Ala Ala Ser Cys Glu
145 150 155 160
Pro Leu Ala Ser Val Leu Arg Ala Lys Pro Asp Phe Lys Glu Leu Thr
165 170 175
Val Ser Asn Asn Asp Ile Asn Glu Ala Gly Val Arg Val Leu Cys Gln
180 185 190
Gly Leu Lys Asp Ser Pro Cys Gln Leu Glu Ala Leu Lys Leu Glu Ser
195 200 205
Cys Gly Val Thr Ser Asp Asn Cys Arg Asp Leu Cys Gly Ile Val Ala
210 215 220
Ser Lys Ala Ser Leu Arg Glu Leu Ala Leu Gly Ser Asn Lys Leu Gly
225 230 235 240
Asp Val Gly Met Ala Glu Leu Cys Pro Gly Leu Leu His Pro Ser Ser
245 250 255
Arg Leu Arg Thr Leu Trp Ile Trp Glu Cys Gly Ile Thr Ala Lys Gly
260 265 270
Cys Gly Asp Leu Cys Arg Val Leu Arg Ala Lys Glu Ser Leu Lys Glu
275 280 285
Leu Ser Leu Ala Gly Asn Glu Leu Gly Asp Glu Gly Ala Arg Leu Leu
290 295 300
Cys Glu Thr Leu Leu Glu Pro Gly Cys Gln Leu Glu Ser Leu Trp Val
305 310 315 320
Lys Ser Cys Ser Phe Thr Ala Ala Cys Cys Ser His Phe Ser Ser Val
325 330 335
Leu Ala Gln Asn Arg Phe Leu Leu Glu Leu Gln Ile Ser Asn Asn Arg
340 345 350
Leu Glu Asp Ala Gly Val Arg Glu Leu Cys Gln Gly Leu Gly Gln Pro
355 360 365
Gly Ser Val Leu Arg Val Leu Trp Leu Ala Asp Cys Asp Val Ser Asp
370 375 380
Ser Ser Cys Ser Ser Leu Ala Ala Thr Leu Leu Ala Asn His Ser Leu
385 390 395 400
Arg Glu Leu Asp Leu Ser Asn Asn Cys Leu Gly Asp Ala Gly Ile Leu
405 410 415
Gln Leu Val Glu Ser Val Arg Gln Pro Gly Cys Leu Leu Glu Gln Leu
420 425 430
Val Leu Tyr Asp Ile Tyr Trp Ser Glu Glu Met Glu Asp Arg Leu Gln
435 440 445
Ala Leu Glu Lys Asp Lys Pro Ser Leu Arg Val Ile Ser
450 455 460
<210> 2
<211> 1386
<212> DNA
<213> Human (Human)
<400> 2
atgagcctgg acatccagag cctggacatc cagtgtgagg agctgagcga cgctagatgg 60
gccgagctcc tccctctgct ccagcagtgc caagtggtca ggctggacga ctgtggcctc 120
acggaagcac ggtgcaagga catcagctct gcacttcgag tcaaccctgc actggcagag 180
ctcaacctgc gcagcaacga gctgggcgat gtcggcgtgc attgcgtgct ccagggcctg 240
cagaccccct cctgcaagat ccagaagctg agcctccaga actgctgcct gacgggggcc 300
ggctgcgggg tcctgtccag cacactacgc accctgccca ccctgcagga gctgcacctc 360
agcgacaacc tcttggggga tgcgggcctg cagctgctct gcgaaggact cctggacccc 420
cagtgccgcc tggaaaagct gcagctggag tattgcagcc tctcggctgc cagctgcgag 480
cccctggcct ccgtgctcag ggccaagccg gacttcaagg agctcacggt tagcaacaac 540
gacatcaatg aggctggcgt ccgtgtgctg tgccagggcc tgaaggactc cccctgccag 600
ctggaggcgc tcaagctgga gagctgcggt gtgacatcag acaactgccg ggacctgtgc 660
ggcattgtgg cctccaaggc ctcgctgcgg gagctggccc tgggcagcaa caagctgggt 720
gatgtgggca tggcggagct gtgcccaggg ctgctccacc ccagctccag gctcaggacc 780
ctgtggatct gggagtgtgg catcactgcc aagggctgcg gggatctgtg ccgtgtcctc 840
agggccaagg agagcctgaa ggagctcagc ctggccggca acgagctggg ggatgagggt 900
gcccgactgc tgtgtgagac cctgctggaa cctggctgcc agctggagtc gctgtgggtg 960
aagtcctgca gcttcacagc cgcctgctgc tcccacttca gctcagtgct ggcccagaac 1020
aggtttctcc tggagctaca gataagcaac aacaggctgg aggatgcggg cgtgcgggag 1080
ctgtgccagg gcctgggcca gcctggctct gtgctgcggg tgctctggtt ggccgactgc 1140
gatgtgagtg acagcagctg cagcagcctc gccgcaaccc tgttggccaa ccacagcctg 1200
cgtgagctgg acctcagcaa caactgcctg ggggacgccg gcatcctgca gctggtggag 1260
agcgtccggc agccgggctg cctcctggag cagctggtcc tgtacgacat ttactggtct 1320
gaggagatgg aggaccggct gcaggccctg gagaaggaca agccatccct gagggtcatc 1380
tcctga 1386
Claims (10)
1. An insect-resistant protein hRI, which is characterized in that the amino acid sequence of the insect-resistant protein hRI is shown as the sequence 1 in the sequence table.
2. The gene for coding the insect-resistant protein hRI of claim 1, wherein the gene sequence is shown as a sequence 2 in a sequence table.
3. A recombinant vector comprising the gene fragment of claim 2.
4. The recombinant vector according to claim 3, wherein the recombinant vector is constructed by: the gene fragment shown in the sequence 2 in the sequence table is connected to the pBIN438 plasmid, thereby constituting the plant expression vector pBIN 438-hRI.
5. A recombinant strain comprising the recombinant vector of claim 2 or 3, wherein the recombinant strain is agrobacterium tumefaciens.
6. Use of the insect-resistant protein hRI of claim 1 and the gene of claim 2 to improve insect resistance in a plant.
7. The use of claim 6, wherein the gene fragment of claim 2 is introduced into a plant of interest to obtain a transgenic plant, and wherein the insect-resistant protein hRI is expressed in the transgenic plant, thereby rendering the transgenic plant more insect-resistant than the plant of interest.
8. The use according to claim 7, wherein the gene fragment of claim 2 is introduced into a plant of interest by the recombinant vector of claim 3 or 4.
9. Use according to claim 7 or 8, wherein said insect resistance is against cotton bollworm.
10. The use according to claim 7 or 8, wherein the plant of interest is upland cotton or tobacco.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111469961.3A CN114316015A (en) | 2021-12-03 | 2021-12-03 | Insect-resistant protein hRI and coding gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111469961.3A CN114316015A (en) | 2021-12-03 | 2021-12-03 | Insect-resistant protein hRI and coding gene and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114316015A true CN114316015A (en) | 2022-04-12 |
Family
ID=81049330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111469961.3A Pending CN114316015A (en) | 2021-12-03 | 2021-12-03 | Insect-resistant protein hRI and coding gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114316015A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043415A (en) * | 1996-10-07 | 2000-03-28 | Ramot Univ. Auth. For Applied Research And Industrial Development Ltd. | Synthetic Bacillus thuringiensis cryic gene encoding insect toxin |
CN1726395A (en) * | 2002-12-17 | 2006-01-25 | 北京诺赛基因组研究中心有限公司 | Specific markers for pancreatic cancer |
CN107474120A (en) * | 2017-08-16 | 2017-12-15 | 中国农业大学 | The artificial synthesized Bt killing genes mcry1F for transgenic anti-insect plants |
-
2021
- 2021-12-03 CN CN202111469961.3A patent/CN114316015A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6043415A (en) * | 1996-10-07 | 2000-03-28 | Ramot Univ. Auth. For Applied Research And Industrial Development Ltd. | Synthetic Bacillus thuringiensis cryic gene encoding insect toxin |
CN1726395A (en) * | 2002-12-17 | 2006-01-25 | 北京诺赛基因组研究中心有限公司 | Specific markers for pancreatic cancer |
CN107474120A (en) * | 2017-08-16 | 2017-12-15 | 中国农业大学 | The artificial synthesized Bt killing genes mcry1F for transgenic anti-insect plants |
Non-Patent Citations (2)
Title |
---|
NCBI: "Homo sapiens ribonuclease/angiogenin inhibitor 1 (RNH1), transcript variant 1, mRNA", Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/nuccore/1676319201?sat=50&satkey=94458483> * |
郭线茹等: "转基因抗虫烟草研究进展", 昆虫知识, vol. 42, no. 4, 31 December 2005 (2005-12-31), pages 358 - 363 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Li et al. | Host-derived suppression of nematode reproductive and fitness genes decreases fecundity of Heterodera glycines Ichinohe | |
Epple et al. | ESTs reveal a multigene family for plant defensins in Arabidopsis thaliana | |
CA2621874C (en) | Plants modified with mini-chromosomes | |
CN102498220B (en) | The centromeric sequence of sugarcane and minichromosome | |
WO2001096584A2 (en) | Materials and methods for the control of nematodes | |
CN107653258B (en) | Application of cotton GhLecRK1 gene in plant verticillium wilt resistance | |
WO2022073260A1 (en) | Application of tomato hydroxyproline-rich systemin precursor protein gene slhypsys in improving resistance of plants to verticillium wilt | |
MX2014009113A (en) | Pathogen resistant citrus compositions, organisms, systems, and methods. | |
CN110358776B (en) | Rhizoctonia solani pathogenic related gene and application thereof | |
CN105838726B (en) | A kind of Salt Tolerance Gene in Alfalfa gene M sCDPK and its coding albumen and application | |
CN108997487B (en) | Application of stress resistance-related protein Z76 in regulation and control of plant stress resistance | |
CN110669762B (en) | Nucleotide sequences and methods for controlling insect infestation | |
CN103937819B (en) | A kind of lilium regale wilson glutathione S-transferase gene LrGSTL1 and application thereof | |
CN110862996A (en) | Application of isolated soybean gene in improving soybean cyst nematode resistance | |
CN101548013B (en) | Gmrd22-like genes and use thereof to protect against abiotic stress | |
Bradshaw Jr et al. | Wound-responsive gene expression in poplars | |
CN107663232B (en) | Plant anti-adversity associated protein OsIAA18 and its encoding gene and application | |
CN114316015A (en) | Insect-resistant protein hRI and coding gene and application thereof | |
CN111808832B (en) | Gene of cation transfer ATP enzyme of rhizoctonia solani, fragment Rscta thereof and application | |
CN102559703B (en) | Glyphosate-resistant herbicide gene AroA-Ra from grape crown gall antagonistic bacteria rahnella aquatilis and application thereof | |
CN108866074B (en) | Application of herbicide-resistant gene PAR3(G311E) | |
CN103146711B (en) | Artificially synthesized aphid-resistant gene ASGNA (artificial synthetic galanthus nivalis agglutinin), as well as synthesizing method and application thereof | |
CN113604475B (en) | Application of cotton GH_D03G1517 gene in promotion of drought resistance and salt tolerance | |
KR100796164B1 (en) | Plant membrane receptor protein gene camrp1 from pepper and environmental stress resistant transgenic plants using the same | |
CN114716521B (en) | Maize drought-resistant related protein and application thereof in plant drought resistance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |